Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada flag Canada · Delayed Price · Currency is CAD
18.28
-0.23 (-1.24%)
Apr 28, 2026, 4:00 PM EST

Cipher Pharmaceuticals Revenue

In the year 2025, Cipher Pharmaceuticals had annual revenue of $50.45M USD with 51.22% growth. Cipher Pharmaceuticals had revenue of $12.22M in the quarter ending December 31, 2025, with 3.35% growth.

Revenue
$50.45M
Revenue Growth
+51.22%
P/S Ratio
6.71
Revenue / Employee
$10.09M
Employees
5
Market Cap
464.15M CAD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202550.45M17.09M51.22%
Dec 31, 202433.36M12.20M57.66%
Dec 31, 202321.16M487.00K2.36%
Dec 31, 202220.68M-1.27M-5.78%
Dec 31, 202121.94M336.00K1.56%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cresco Labs 899.24M
Canopy Growth 278.39M
Verano Holdings 1.13B
TerrAscend 357.26M
Knight Therapeutics 450.09M
Aurora Cannabis 373.12M
Organigram Global 279.99M
DRI Healthcare Trust 263.00M
Revenue Rankings